Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Lubna Choudhury et al.|New England Journal of Medicine|2024Cited by 277
Clinical Outcome Endpoints in Heart Failure Trials: A European Society of Cardiology Heart Failure Association Consensus DocumentFaı̈ez Zannad, John J.V. McMurray, Ángeles García et al.|European Journal of Heart Failure|2013Cited by 233
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Ahmad Masri et al.|Journal of the American College of Cardiology|2023Cited by 192